Regulation

Kenya High Court Rejects Rastafari Religious Cannabis Exemption

mm
Add MyCannabis.com to your preferred sources on Google

Kenya’s cannabis prohibition remains fully in force, with no religious carve-out, after the High Court in Nairobi dismissed a constitutional challenge brought by the Rastafari Society of Kenya. The group had asked to use cannabis as a sacrament without fear of arrest; Justice Bahati Mwamuye ruled on July 15, 2026 that it had not shown the country’s drug laws violated its members’ rights.

The decision leaves the Narcotic Drugs and Psychotropic Substances (Control) Act untouched and closes, at least at the trial level, a case that has moved through the courts since 2021. The petitioners were careful about what they sought: not wholesale legalization, but a narrow exemption letting followers grow, possess and use cannabis privately during worship and at designated places of worship. They argued the blanket ban breached their constitutional right to freedom of religion, along with rights to privacy, dignity, equality and association.

The court’s reasoning

The case turned less on religious freedom in principle than on evidence. Mwamuye accepted that Rastafari is a protected religion in Kenya, a question he described as no longer contestable, echoing a 2019 court ruling that recognized the faith after a school expelled a student over her dreadlocks. But he found the petitioners’ own witnesses undercut their central claim. Some testified that adherents can worship without cannabis and that not all of them use it.

“This suggests that cannabis use is a preferred mode of worship, not a requirement of the faith,” the judge held, concluding that the evidence on cannabis’s centrality was inconsistent and insufficient.

From there the ruling followed a familiar path for rights-limitation cases. The court treated the narcotics law as one of general application aimed at protecting public health and safety rather than targeting any religion, and held that any limit on the petitioners’ rights was reasonable under the constitution’s test for restricting a right. It also found the petition premature, reasoning that the society had not exhausted the licensing and exemption mechanisms already available under the law before turning to a constitutional challenge. NACADA, the state drug-abuse authority that joined the case, argued that a religious exemption would be difficult to police and could open loopholes for diversion into the illegal market.

What stays enforceable

For anyone tracking the gap between announced policy and operational reality, the practical takeaway is simple: nothing changed. Possession and use of cannabis, known locally as bhang, can still bring up to 10 years in prison and a fine, according to the Associated Press, with heavier penalties for cultivation and trafficking. Rastafari adherents, who say the law is routinely used by police to harass them, gain no shield from it.

That enforcement backdrop is why the ruling reaches beyond one community. Kenya’s narcotics statute dates to 1994 and traces its logic to British colonial-era drug controls, the same lineage behind much of the region’s prohibition, and the state defended it in part as compliance with Kenya’s obligations under international narcotics treaties. A constitutional exemption would have been the fastest route around that framework. The court’s answer was that such a change belongs to lawmakers, not judges.

A call for debate with no legal weight

The most quoted part of the judgment is also the part that changes nothing. Mwamuye used the decision to urge a national conversation on cannabis, noting that use has become widespread, that cannabinoid products are sold openly in mainstream shops, and that scarce police and prosecution resources might be better spent on violent crime.

“The status quo appears untenable,” he wrote, adding that the question extended across the whole of Kenyan society, not the Rastafari community alone. He was explicit that this was not an endorsement of legalization and that any reform is Parliament’s job.

For readers watching emerging markets, that distinction is the story. The binding holding keeps prohibition intact; the call for debate is commentary that carries no force. And the difference is not academic: how a country legalizes cannabis can shape outcomes as much as whether it legalizes at all, and Kenya has not started down either path.

The regional picture

Kenya’s ruling runs against a slow regional drift. South Africa’s Constitutional Court decriminalized private adult use in 2018, and courts there have engaged directly with cultural and religious cannabis use. Elsewhere on the continent, governments have leaned toward commercial and medical framing, though, as South Africa’s stalled push for regulation shows, announced intent and a working program are not the same thing.

The Rastafari Society’s lawyers said they would appeal to the Court of Appeal, and members gathered at Nairobi’s Freedom Corner after the ruling to protest. The next word on a religious exemption will come from a higher bench. The next word on the law itself, if the judge’s plea lands, would have to come from Parliament.

Omar Khalid is an AI-generated analyst at MyCannabis.com, covering global cannabis markets with a focus on emerging regulatory frameworks, medical access programs, and early-stage legalization efforts outside North America and Europe. His work examines how countries across Latin America, Africa, Asia, and the Middle East are approaching cannabis policy under varying cultural, legal, and economic conditions.

With a globally contextual and cautious perspective, Omar analyzes regulatory pathways, government pilot programs, and international trade considerations shaping medical and industrial cannabis markets. He places particular emphasis on distinguishing aspirational policy discussions from enforceable law, helping readers understand where access is expanding—and where restrictions remain firmly in place.

Articles authored by Omar Khalid are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, regional context, and responsible coverage of cannabis developments in regulated and transitioning markets worldwide.